Welcome to the Lymphedema Treatment Act website!
The Lymphedema Treatment Act (HR 3877) will improve coverage for the treatment of lymphedema from any cause. Untreated lymphedema is progressive and leads to infection, disfigurement, disability and in some cases even death. Thus, prognosis for the patient is far worse and treatment more costly when the disease is not properly managed.
The Lymphedema Treatment Act was introduced into the current Congress on January 15, 2014.
Note that cosponsors do not carry over from one Congress to the next, so even if your Representative
cosponsored this bill in the past, he or she must sign on again. Please write your Representative today!
WE NEED YOUR HELP! We have no paid lobbyists; our cause is entirely grassroots and patient driven. Please explore the site to learn more, then complete as many of the simple steps under the “How You Can Help” menu
as you can. The single most important thing you can do is take just a couple of minutes to
Contact your members of Congress using our simple submission form.
Although this legislation relates specifically to a change in Medicare law, it would set a precedent for Medicaid and private insurers to follow. For more detailed information please visit our About The Bill page.
Specific goals of the Act are as follows:
- to provide comprehensive lymphedema treatment coverage, according to current
medical treatment standards;
- to enable patient self-treatment plan adherence by providing necessary medical supplies
for use at home, as prescribed for each patient (including gradient compression
garments, bandages, and other compression devices);
- to reduce the total healthcare costs associated with this disease by decreasing the incidence of
complications, co-morbidities and disabilities resulting from this medical condition.